06/10/2026
A win for 👏🏿 👏🏾 👏🏽
For years, pulse oximeters have been widely used to measure oxygen levels in blood — but they're less accurate on darker skin, which can lead to delays in treatment and inequitable care for patients of different races.
Now, Medtronic has received FDA clearance for a pulse oximetry system that offers more reliable readings of oxygen saturation across different patient populations, skin tones, and clinical settings.
Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor. The Nell-EQ™ intelligent processor is a new pulse oximetry processing technology designed to support more consistent and reliable oxyg...